Work

Lower drug clearance of adalimumab is associated with proactive therapeutic drug monitoring and mucosal healing in patients with inflammatory bowel disease

Year: 2026

Type: article

Study design: Observational Study

Source: European Journal of Gastroenterology & Hepatology

DOI: 10.1097/meg.0000000000003183

Authors: Tina Deyhim, Alessandra Saraga, Ajay Gade, Grace Geeganage, Mostafa A. Soliman, Samantha Zullow, Loren G. Rabinowitz, Laurie B. Grossberg, Adam S. Cheifetz, Thierry Dervieux, Konstantinos Papamichael

Institutions: Beth Israel Deaconess Medical Center, Harvard University

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7140109941

FWCI: 3.971

Cites: 23

Cited by: 1

Related to: